| (84) |
Designated Contracting States: |
|
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
| (30) |
Priority: |
08.03.2002 US 362735 P
|
| (43) |
Date of publication of application: |
|
22.12.2004 Bulletin 2004/52 |
| (73) |
Proprietors: |
|
- NOVARTIS AG
4056 Basel (CH) Designated Contracting States: BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
- Novartis Pharma GmbH
1230 Wien (AT) Designated Contracting States: AT
|
|
| (72) |
Inventors: |
|
- PRASHAD, Mahavir
Montville, NJ 07045 (US)
- LOHSE, Olivier
F-68170 Rixheim (FR)
- HU, Bin
Greenbrook NJ 08812 (US)
|
| (74) |
Representative: de Weerd, Petrus G.W. et al |
|
Novartis International AG
Corporate Intellectual Property 4002 Basel 4002 Basel (CH) |
| (56) |
References cited: :
EP-A- 0 253 321 WO-A-00/75114
|
EP-A- 1 018 514
|
|
| |
|
|
|
|